Central Bank & Trust Co. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,992 shares of the healthcare conglomerate’s stock after purchasing an additional 134 shares during the quarter. Central Bank & Trust Co.’s holdings in UnitedHealth Group were worth $3,336,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Patriot Financial Group Insurance Agency LLC grew its position in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after purchasing an additional 603 shares during the last quarter. Kings Point Capital Management lifted its stake in shares of UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. Founders Capital Management purchased a new position in shares of UnitedHealth Group during the first quarter valued at approximately $135,000. Parkside Financial Bank & Trust lifted its stake in shares of UnitedHealth Group by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the period. Finally, Hanson McClain Inc. lifted its stake in shares of UnitedHealth Group by 1.7% during the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 15 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

In other news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the sale, the insider now directly owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 76,174 shares of company stock worth $14,981,909. Corporate insiders own 0.89% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/central-bank-trust-co-grows-stake-in-unitedhealth-group-incorporated-unh/1578565.html.

Shares of UnitedHealth Group Incorporated (NYSE UNH) traded down 0.11% during trading on Thursday, hitting $195.54. 686,541 shares of the stock traded hands. The company has a 50 day moving average of $195.56 and a 200-day moving average of $181.26. The company has a market cap of $189.06 billion, a PE ratio of 23.49 and a beta of 0.63. UnitedHealth Group Incorporated has a 1-year low of $133.03 and a 1-year high of $200.76.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same period in the prior year, the company posted $1.96 EPS. The company’s revenue was up 7.7% compared to the same quarter last year. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s payout ratio is presently 35.13%.

A number of research firms have weighed in on UNH. Cantor Fitzgerald reaffirmed a “buy” rating and set a $205.00 price target on shares of UnitedHealth Group in a research note on Friday, July 7th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. Credit Suisse Group reaffirmed an “outperform” rating and set a $200.00 price target (up from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Citigroup Inc. raised their price target on shares of UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and set a $212.00 price target on shares of UnitedHealth Group in a report on Thursday, July 20th. One equities research analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $203.41.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.